RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $404,394 | -81.0% | 32,197 | -75.1% | 0.18% | -89.3% |
| Q1 2023 | $2,128,665 | -19.3% | 129,245 | -26.8% | 1.73% | +10.7% |
| Q4 2022 | $2,637,224 | -29.6% | 176,521 | +5.5% | 1.57% | -26.8% |
| Q3 2022 | $3,744,000 | +97.3% | 167,383 | +47.7% | 2.14% | +86.6% |
| Q2 2022 | $1,898,000 | -7.5% | 113,313 | +65.2% | 1.15% | -12.2% |
| Q1 2022 | $2,053,000 | +45.4% | 68,608 | +49.2% | 1.30% | +16.1% |
| Q4 2021 | $1,412,000 | +18.7% | 45,992 | +21.9% | 1.12% | +42.8% |
| Q3 2021 | $1,190,000 | +39.8% | 37,743 | +62.3% | 0.79% | +30.3% |
| Q2 2021 | $851,000 | +46.0% | 23,250 | +37.8% | 0.60% | +39.5% |
| Q1 2021 | $583,000 | -6.3% | 16,876 | +12.7% | 0.43% | +9.1% |
| Q4 2020 | $622,000 | – | 14,975 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |